Clinical Drug Experience Knowledgebase

Acquired Immunodeficiency Syndrome (Phase 2)

Alcohol Drinking (Phase 2)

Alcoholism (Phase 2)

Anxiety Disorders (Phase 4)

Aspergillosis (Phase 4)

Asthma (Phase 1)

Atrial Fibrillation (Phase 4)

Atrial Flutter (Phase 4)

Bipolar Disorder (Phase 4)

Breast Neoplasms (Phase 4)

Candidiasis (Phase 4)

Candidiasis, Invasive (Phase 4)

Cerebral Hemorrhage (Phase 2)

Cerebral Infarction (Phase 2)

Cognitive Dysfunction (Phase 4)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 3)

Critical Illness (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Diabetic Nephropathies (Phase 3)

Diabetic Retinopathy (Phase 3)

Disease (Phase 4)

Emergencies (Phase 3)

Epidermolysis Bullosa (Phase 3)

Epilepsy, Complex Partial (Phase 1)

Fabry Disease (Phase 3)

Glomerulonephritis (Phase 3)

Hematologic Neoplasms (Phase 2)

Hemorrhage (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

HIV Infections (Phase 2)

Hyperglycemia (Phase 4)

Immunologic Deficiency Syndromes (Phase 3)

Infarction (Phase 4)

Infections (Phase 4)

Invasive Fungal Infections (Phase 4)

Ischemia (Phase 2)

Kidney Diseases (Phase 3)

Leukemia (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Lung Neoplasms (Phase 4)

Mental Disorders (Phase 4)

Multiple Myeloma (Phase 1)

Multiple Sclerosis (Phase 3)

Mycoses (Phase 4)

Myeloproliferative Disorders (Phase 2)

Myocardial Infarction (Phase 4)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 1)

Oliguria (Phase 2)

Parasomnias (Phase 2)

Parkinson Disease (Phase 1)

Polycythemia (Phase 2)

Polycythemia Vera (Phase 2)

Primary Myelofibrosis (Phase 2)

Proteinuria (Phase 3)

Psychotic Disorders (Phase 4)

Recurrence (Phase 4)

Renal Insufficiency (Phase 3)

Retinal Diseases (Phase 3)

Schizophrenia (Phase 4)

Sclerosis (Phase 3)

Shock (Phase 2)

Shock, Septic (Phase 2)

Sleep Initiation and Maintenance Disorders (Phase 2)

Sleep Wake Disorders (Phase 2)

Stroke (Phase 2)

Substance-Related Disorders (Phase 2)

Syndrome (Phase 2)

Systemic Inflammatory Response Syndrome (Phase 2)

Thrombocythemia, Essential (Phase 2)

Thrombocytosis (Phase 2)

Thrombosis (Phase 4)

Tremor (Phase 3)

Vasoplegia (Phase 2)

Venous Thrombosis (Phase 4)